Villemagne VL - Search Results

1

Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET.

Mitkovski S, Villemagne VL, Novakovic KE, O'Keefe G, Tochon-Danguy H, Mulligan RS, Dickinson KL, Saunder T, Gregoire MC, Bottlaender M, Dolle F, Rowe CC. Mitkovski S, et al. Among authors: villemagne vl. Nucl Med Biol. 2005 Aug;32(6):585-91. doi: 10.1016/j.nucmedbio.2005.04.013. Nucl Med Biol. 2005. PMID: 16026705

2

Imaging histamine H1 receptors in the living human brain with carbon-11-pyrilamine.

Villemagne VL, Dannals RF, Sánchez-Roa PM, Ravert HT, Vazquez S, Wilson AA, Natarajan TK, Wong DF, Yanai K, Wagner HN Jr. Villemagne VL, et al. J Nucl Med. 1991 Feb;32(2):308-11. J Nucl Med. 1991. PMID: 1992035 Free article.

3

Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog.

Villemagne VL, Horti A, Scheffel U, Ravert HT, Finley P, Clough DJ, London ED, Wagner HN Jr, Dannals RF. Villemagne VL, et al. J Nucl Med. 1997 Nov;38(11):1737-41. J Nucl Med. 1997. PMID: 9374343 Free article.

4

Synthesis of an I-123 analog of A-85380 and preliminary SPECT imaging of nicotinic receptors in baboon.

Musachio JL, Villemagne VL, Scheffel UA, Dannals RF, Dogan AS, Yokoi F, Wong DF. Musachio JL, et al. Among authors: villemagne vl. Nucl Med Biol. 1999 Feb;26(2):201-7. doi: 10.1016/s0969-8051(98)00101-2. Nucl Med Biol. 1999. PMID: 10100220 Free article.

5

Image analysis in patients with cancer studied with a combined PET and CT scanner.

Charron M, Beyer T, Bohnen NN, Kinahan PE, Dachille M, Jerin J, Nutt R, Meltzer CC, Villemagne V, Townsend DW. Charron M, et al. Clin Nucl Med. 2000 Nov;25(11):905-10. doi: 10.1097/00003072-200011000-00010. Clin Nucl Med. 2000. PMID: 11079589

6

Sequential H(2)(15)O PET studies in baboons: before and after amphetamine.

Price JC, Drevets WC, Ruszkiewicz J, Greer PJ, Villemagne VL, Xu L, Mazumdar S, Cantwell MN, Mathis CA. Price JC, et al. Among authors: villemagne vl. J Nucl Med. 2002 Aug;43(8):1090-100. J Nucl Med. 2002. PMID: 12163636 Free article.

7

Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease.

Villemagne VL, Rowe CC, Macfarlane S, Novakovic KE, Masters CL. Villemagne VL, et al. J Clin Neurosci. 2005 Apr;12(3):221-30. doi: 10.1016/j.jocn.2004.03.011. J Clin Neurosci. 2005. PMID: 15851069 Review.

8

Rare genetically defined causes of dementia.

Novakovic KE, Villemagne VL, Rowe CC, Masters CL. Novakovic KE, et al. Among authors: villemagne vl. Int Psychogeriatr. 2005;17 Suppl 1:S149-94. doi: 10.1017/s1041610205002012. Int Psychogeriatr. 2005. PMID: 16240489 Review.

9

Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease.

Opazo C, Luza S, Villemagne VL, Volitakis I, Rowe C, Barnham KJ, Strozyk D, Masters CL, Cherny RA, Bush AI. Opazo C, et al. Among authors: villemagne vl. Aging Cell. 2006 Feb;5(1):69-79. doi: 10.1111/j.1474-9726.2006.00196.x. Aging Cell. 2006. PMID: 16441845 Free article.

10

The quest for Eldorado: development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain.

Horti AG, Villemagne VL. Horti AG, et al. Among authors: villemagne vl. Curr Pharm Des. 2006;12(30):3877-900. doi: 10.2174/138161206778559605. Curr Pharm Des. 2006. PMID: 17073685 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

467 results

Search Page

Filters